To give or not to give a vaccine against Covid-19 to patients with IBD?
Authors:
Bortlík M.
Authors place of work:
Gastroenterologické oddělení, Nemocnice České Budějovice, a. s.
Published in the journal:
Gastroent Hepatol 2021; 75(1): 8-9
Category:
Editorial
Zdroje
1. Alexander JL, Moran GW, Gaya DR et al. SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statement. Lancet Gastroenterol Hepatol 2021; 6(3): 218–224. doi: 10.1016/ S2468-1253(21)00024-8.
2. Al-Ani AH, Prentice RE, Rentsch CA et al. Review article: prevention, diagnosis and management of COVID-19 in the IBD patient. Aliment Pharmacol Ther 2020; 52(1): 54–72. doi: 10.1111/ apt.15779.
3. Siegel CA, Melmed GY, McGovern DP et al. SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting. Gut 2021. doi: 10.1136/ gutjnl-2020-324000.
4. Pracovní skupina pro IBD při ČGS ČLS JEP. Stanovisko k vakcinaci proti onemocnění COVID-19 u pacientů s Crohnovou chorobou a ulcerózní kolitidou. [on-line]. Dostupné na: https:/ / www.cgs-cls.cz/ stanovisko-pracovni-skupiny-pro-ibd-pri-cgs-cls-jep-k-vakcinaci-proti-onemocneni-covid-19-u-pacientu-s-crohnovou-chorobou-a-ulcerozni-kolitidou/ .
Štítky
Paediatric gastroenterology Gastroenterology and hepatology SurgeryČlánok vyšiel v časopise
Gastroenterology and Hepatology
2021 Číslo 1
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- Metamizole vs. Tramadol in Postoperative Analgesia
- Spasmolytic Effect of Metamizole
- Possibilities of Using Metamizole in the Treatment of Acute Primary Headaches
- Current Insights into the Antispasmodic and Analgesic Effects of Metamizole on the Gastrointestinal Tract
Najčítanejšie v tomto čísle
- A rare cause of the small bowel ulcers
- Psychological aspects and possibilities of psychological intervention in patients with infl ammatory bowel disease
- Proton pump inhibitors – do we know them well and are they really that safe? – part 3
- (Un)conventional complicated pancreatitis